2seventy bio, the cell therapy spinout of Bluebird bio, is selling itself to Bristol Myers Squibb after losing most of its market value in its short run as an independent biotechnology company. Per ...
Bluebird bio went from a high-flying $10 billion company in 2018 during the heyday of gene therapy to being sold for a measly $29 million … ...
Blue Bird is unveiling its propane-powered stripped chassis based on a 208-inch wheelbase for medium- to long-range delivery vehicles with a gross vehicle weight rating (GVWR) of up to 23,000 lbs. The ...
Bluebird Kids Health, a value-based pediatric primary care provider, has closed its series A round with $31.5 million. The round was co-led by F Prime and .406 Ventures with participation from ...
BOSTON, March 4, 2025 /PRNewswire/ -- Bluebird Kids Health, a new healthcare services company designed to deliver value-based pediatric primary care, today announced the closing of a $31.5 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback